Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Mono-Country and Multi-center Study to Observe Safety and Effectiveness of Adalimumab in KoREan Intestinal Behcet's Disease(BD) Patients

NCT02687828 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02687828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02687828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Mono-Country and Multi-center Study to Observe Safety and Effectiveness of Adalimumab in KoREan Intestinal Behcet's Disease(BD) Patients
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
February 18, 2016
Completion date
March 30, 2020
Enrollment
59 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

intestinal behcet's disease (bd)